More trials on early treatment with corticosteroids are needed
- PMID: 10742018
- PMCID: PMC1117853
More trials on early treatment with corticosteroids are needed
Comment on
-
Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed.BMJ. 1999 Nov 27;319(7222):1385-6. doi: 10.1136/bmj.319.7222.1385. BMJ. 1999. PMID: 10574836 Free PMC article. No abstract available.
Similar articles
-
Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.Pediatrics. 2010 Oct;126(4):800-8. doi: 10.1542/peds.2010-1534. Epub 2010 Sep 6. Pediatrics. 2010. PMID: 20819899
-
Evaluation of hypothalamic-pituitary-adrenal axis in premature infants treated with dexamethasone.Am J Perinatol. 1996 Nov;13(8):473-7. doi: 10.1055/s-2007-994430. Am J Perinatol. 1996. PMID: 8989477
-
Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams.J Perinatol. 2002 Apr-May;22(3):204-8. doi: 10.1038/sj.jp.7210699. J Perinatol. 2002. PMID: 11948382
-
Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.Pediatrics. 2010 Oct;126(4):e954-64. doi: 10.1542/peds.2010-0597. Epub 2010 Sep 13. Pediatrics. 2010. PMID: 20837588 Review.
-
The effect of postnatal steroids on growth and development.J Perinat Med. 2001;29(4):281-5. doi: 10.1515/JPM.2001.040. J Perinat Med. 2001. PMID: 11565195 Review.
Cited by
-
Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Cochrane Database Syst Rev. 2017 Oct 24;10(10):CD001146. doi: 10.1002/14651858.CD001146.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2021 Oct 21;10:CD001146. doi: 10.1002/14651858.CD001146.pub6. PMID: 29063585 Free PMC article. Updated.
-
The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs.BMC Pediatr. 2001;1:1. doi: 10.1186/1471-2431-1-1. Epub 2001 Feb 27. BMC Pediatr. 2001. PMID: 11248841 Free PMC article.
-
Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.J Pediatr. 2014 Jan;164(1):34-39.e2. doi: 10.1016/j.jpeds.2013.07.027. Epub 2013 Aug 27. J Pediatr. 2014. PMID: 23992673 Free PMC article.
-
Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Cochrane Database Syst Rev. 2021 Oct 21;10(10):CD001146. doi: 10.1002/14651858.CD001146.pub6. Cochrane Database Syst Rev. 2021. PMID: 34674229 Free PMC article.
-
Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Cochrane Database Syst Rev. 2021 Nov 11;11(11):CD001145. doi: 10.1002/14651858.CD001145.pub5. Cochrane Database Syst Rev. 2021. PMID: 34758507 Free PMC article.
References
-
- Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101:e7. http://intl.pediatrics.org/ ( http://intl.pediatrics.org/). ). - PubMed
-
- Halliday HL, Ehrenkranz RA. Cochrane library. Issue 3. Oxford: Update Software; 1999. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Collaboration.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical